Wendy Stock, MD, Co-Chair, 2017 ASH Meeting on Hematologic Malignancies
671 views · Published 18 January 2017 · 0:55 · Indexed 14 November 2026
Channel: American Society of Hematology · 2017 · Nonprofits & Activism
Wendy Stock, MD, discusses the 2017 ASH Meeting on Hematologic Malignancies (MHM) and why the meeting is applicable to individuals across the field of hematology. Visit http://www.hematology.org/malignancies/ to learn more about MHM, which provides an opportunity for practicing hematologists, researchers, trainees, and other health-care professionals who specifically support hematologists to get a review of the most recent scientific data placed in a therapeutic context. In addition to getting a snapshot into the latest advances and treatment approaches in leukemia, lymphoma, myelodysplastic syndromes, myeloma, and myeloproliferative neoplasms, attendees also have the ability to interact with experts in the field.
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding